Results 201 to 210 of about 104,970 (255)

Dengue Virus Molecular Targets and Antiviral Drug Development: Advances, Challenges and Therapeutic Perspectives

open access: yesChemistrySelect, Volume 11, Issue 33, 1 September 2026.
This narrative review analyzes DENV molecular targets, including structural proteins (C, prM/M, E), non‐structural components (NS1NS5), and host factors, alongside small‐molecule candidates in preclinical and clinical phases. Owing to high structural conservation, the NS2B‐NS3 protease and NS5 (RdRp/MTase) remain primary drug discovery focuses, while ...
Aryane Lucia da Silva Aguiar De Oliveira   +8 more
wiley   +1 more source

Design and Synthesis of a Potent, Cell Active Purine‐Based Amidoxime Against the Dengue Virus

open access: yesChemistrySelect, Volume 11, Issue 36, 22 September 2026.
Scaffold hopping from our previous indolazepinone hit exemplifies purine SP‐835G with DENV2 EC50 0.1 µM, CC50>100 µM, clogP 3.61. Docking studies support its amidine metabolite operates as an allosteric inhibitor of DENV(pro). A flexible ether linker appears pivotal for enhancing binding and activity.
Dimitrios Kiousis   +8 more
wiley   +1 more source

Nanoscopy reveals heparan sulfate clusters as docking sites for SARS-CoV-2 attachment and entry. [PDF]

open access: yesElife
Han S   +13 more
europepmc   +1 more source

PIM1 and PIM3 Kinases Suppress HIV-1 Protein Expression and Particle Production Through Distinct Roles. [PDF]

open access: yesPathogens
Tran KQ   +13 more
europepmc   +1 more source

Beyond assembly: functions of the coronavirus M protein. [PDF]

open access: yesVirol J
Kariuki CK   +5 more
europepmc   +1 more source

Scavenger Receptor Class F Member 2: An Intracellular Receptor Escorting Hepatitis B Virus From Endosome to Nuclear Pore

open access: yes
MedComm – Future Medicine, Volume 5, Issue 3, September 2026.
Yujing Ng, Lin Du, Huahao Fan
wiley   +1 more source

Home - About - Disclaimer - Privacy